Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population

被引:72
|
作者
Hiratsuka, M [1 ]
Inoue, T [1 ]
Omori, F [1 ]
Agatsuma, Y [1 ]
Mizugaki, M [1 ]
机构
[1] Tohoku Univ Hosp, Dept Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
thiopurine methyltransferase; pharmacogenetics; genetic polymorphism;
D O I
10.1016/S0027-5107(00)00004-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Thiopurine methyltransferase (TPMT) catalyses the S-methylation of thiopurine drugs such as 6-mercaptopurine, B-thioguanine, and azathiopurine. Several mutations in the TPMT gene have been identified which correlate with a low activity phenotype. The molecular basis for the genetic polymorphism of TPMT has been established for European Caucasians, African-Americans, Southwest Asians and Chinese, but it remains to be elucidated in Japanese populations. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A (G460A and A719G), TPMT*3B (G460A) and TPMT*3C (A719G) were determined in Japanese samples (n=192) using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. TPMT*3C was found in 0.8% of the samples (three heterozygotes). The TPMT*2, TPMT*3A and TPMT*3B alleles were not detected in any of the samples analyzed. This study provides the first analysis of TPMT mutant allele frequency in a sample of Japanese population and indicates that TPMT*3C is the most common allele in Japanese subjects. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 50 条
  • [41] Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype
    Arenas, M
    Marinaki, A
    Lewis, CM
    Shobowale-Bakre, EM
    Escuredo, E
    Fairbanks, L
    Ansari, A
    Sanderson, JD
    Duley, JA
    GUT, 2003, 52 : A65 - A65
  • [42] Frequency distribution of thiopurine S-methyltransferase activity in red blood cells of a healthy Japanese population
    Kubota, T
    Nishida, A
    Takeuchi, K
    Iida, T
    Yokota, H
    Higashi, K
    Nakahara, K
    Hanai, H
    Iga, T
    THERAPEUTIC DRUG MONITORING, 2004, 26 (03) : 319 - 321
  • [43] Thiopurine methyltransferase activity in a Korean population sample of children
    ParkHah, JO
    Klemetsdal, B
    Lysaa, R
    Choi, KH
    Aarbakke, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (01) : 68 - 74
  • [44] THIOPURINE S-METHYLTRANSFERASE ACTIVITY IN A CHINESE POPULATION
    LEE, EJD
    KALOW, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (01) : 28 - 33
  • [45] Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype
    Ansari, AR
    Arenas, M
    Mannaki, T
    Lewis, K
    Shobowale-Bakre, EMA
    Fairbanks, L
    Escuredo, E
    Duley, J
    Sanderson, J
    GASTROENTEROLOGY, 2003, 124 (04) : A200 - A200
  • [46] Pharmacoeconomic analysis of thiopurine methyltransferase polymorphism screening by polymerase chain reaction for treatment with azathioprine in Korea
    Oh, KT
    Anis, AH
    Bae, SC
    RHEUMATOLOGY, 2004, 43 (02) : 156 - 163
  • [47] Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2020, 31 (05) : 1154 - 1155
  • [48] GENETIC-POLYMORPHISM OF PIF PROTEINS IN A JAPANESE POPULATION
    IKEMOTO, S
    TSUCHIDA, S
    NISHIUMI, E
    TOMITA, K
    HUMAN HEREDITY, 1987, 37 (04) : 263 - 264
  • [49] GENETIC-POLYMORPHISM OF HAPTOGLOBIN SUBTYPES IN A JAPANESE POPULATION
    NAKADA, N
    ABE, K
    HUMAN HEREDITY, 1987, 37 (06) : 376 - 380
  • [50] Catechol-O-methyltransferase (COMT) genetic polymorphism in a Turkish population
    Kocabas, NA
    Karakaya, AE
    Cholerton, S
    Sardas, S
    ARCHIVES OF TOXICOLOGY, 2001, 75 (07) : 407 - 409